Open tender · Germany · Contract notice
Open house Arzneimittelrabattverträge Erythropoietin alfa, ATC B03XA01
AOK Bayern - Die Gesundheitskasse
AOK Bayern - Die Gesundheitskasse in Germany is inviting bids for “Open house Arzneimittelrabattverträge Erythropoietin alfa, ATC B03XA01”. Bids close on 3 July 2027.
The work
Non-exclusive discount agreements for the active substance Erythropoietin alfa (ATC B03XA01) with AOK Bayern.
- Identical and non-negotiable discount agreements
- Contract end date is 31.08.2027
- Contracts can be terminated with one month's notice at the end of a month
Key facts
- Contract period
- From 01.09.2025 to 31.08.2027
- Evaluation
- Not a competitive tender, but an open-house model where all eligible companies receive the same contract.
What it takes to qualify
Worth a closer look
- The tender document is in German and refers to German law (SGB V). The schema is for an Indian government tender. It is unclear if any Indian-specific requirements (like GST, PAN) apply.
- The document mentions 'pharmazeutische Unternehmen' (pharmaceutical companies) as potential partners, but does not specify if this includes manufacturers, wholesalers, or other entities.
Policy conditions
No reservation, preference or local-content restriction.
Documents to submit
- ausgefüllte und unterzeichnete Eigenerklärung zur Zuverlässigkeitmust be signed, representation authority must be evident from trade register extract or a power of attorney must be provided
- ausgefüllter und unterzeichneter Vertragmust be signed, representation authority must be evident from trade register extract or a power of attorney must be provided
- Anlage "Festlegung der vertragsgegenständlichen Arzneimittel"must be filled out and signed